| Literature DB >> 32450277 |
Meritxell Arenas1, Ugur Selek2, Orit Kaidar-Person3, Elisabetta Perrucci4, Angel Montero Luis5, Liesbeth Boersma6, Charlotte Coles7, Birgitte Offersen8, Icro Meattini9, Yasemin Bölükbaşı2, Maria Cristina Leonardi10, Raphael Pfeffer11, Bruno Cutuli12, Cristiana Vidali13, Pierfrancesco Franco14, Vassilis Kouloulias15, Valeria Masiello16, Sofia Rivera17, Céline Bourgier18, Antonella Ciabattoni19, Valentina Lancellotta16, Lurdes Trigo20, Vincenzo Valentini16, Philip Poortmans21, Cynthia Aristei22.
Abstract
We report on the second Assisi Think Tank Meeting (ATTM) on breast cancer which was held under the auspices of the European Society for RadioTherapy & Oncology (ESTRO). In discussing in-depth current evidence and practice it was designed to identify grey areas in diverse forms of the disease. It aimed at addressing uncertainties and proposing future trials to improve patient care. Before the meeting, three key topics were selected: 1) primary systemic therapy, mastectomy, breast reconstruction and post-mastectomy radiation therapy, 2) therapeutic options in ductal carcinoma in situ, and 3) therapy de-escalation in early stage breast cancer. Clinical practice in these areas was investigated by means of an online questionnaire. The time lapse period between the survey and the meeting was used to review the literature and on-going clinical trials. At the ATTM both were discussed in depth and research protocols were proposed.Entities:
Keywords: Breast cancer; Breast reconstruction; De-escalating therapy; Ductal carcinoma in situ; Hypofractionation; Neoadjuvant chemotherapy; Partial breast irradiation; Post-mastectomy radiation therapy; Radiation therapy
Mesh：
Year: 2020 PMID： 32450277 DOI： 10.1016/j.critrevonc.2020.102967
Source DB: PubMed Journal: Crit Rev Oncol Hematol ISSN： 1040-8428 Impact factor: 6.312